Oral evidence transcript
| Published on: | Thursday 2 May 2013 |
|---|---|
| Date: | Monday 22 April 2013 |
| Meeting on: | Monday 22 April 2013 |
| Legacy HTML link: | http://www.publications.parliament.uk/pa/cm201213/cmselect/cmsctech/uc1054-ii/uc105401.htm |
| Legacy PDF link: | http://www.publications.parliament.uk/pa/cm201213/cmselect/cmsctech/uc1054-ii/uc1054.pdf |
| Part of event segment: | Untitled |
Committees
Work packages
- Thursday 13 December 2012 - Monday 18 November 2013
Witnesses
-
Dr Catherine Elliott, Director of Clinical Research Interests, Medical Research Council, Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities, Professor Peter Johnson, Chief Clinician, Cancer Research UK, and Nicola Perrin, Head of Policy, Wellcome Trust; Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry, Dr James Shannon, Chief Medical Officer, GlaxoSmithKline, William M Burns, Member of the Board of Directors, Roche, and Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, London School of Hygiene and Tropical Medicine